Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4442-53-9 | MDL No. : | MFCD00239415 |
Formula : | C9H8O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VCLSWKVAHAJSFL-UHFFFAOYSA-N |
M.W : | 180.16 | Pubchem ID : | 78184 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.27 |
TPSA : | 55.76 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.58 cm/s |
Log Po/w (iLOGP) : | 1.44 |
Log Po/w (XLOGP3) : | 1.16 |
Log Po/w (WLOGP) : | 1.16 |
Log Po/w (MLOGP) : | 0.66 |
Log Po/w (SILICOS-IT) : | 1.5 |
Consensus Log Po/w : | 1.18 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.96 |
Solubility : | 1.96 mg/ml ; 0.0109 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.93 |
Solubility : | 2.14 mg/ml ; 0.0119 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.8 |
Solubility : | 2.84 mg/ml ; 0.0158 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.23 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.332 g | Stage #1: With aminosulfonic acid In water; acetone at 0 - 5℃; for 0.333333 h; Stage #2: With sodium chlorite In water; acetone at 22 - 26℃; for 18 h; |
A solution of 2,3-dihydrobenzo[b][l,4]dioxine-5-carbaldehyde (0.500 g, 3.04 mmol) in acetone (10 mL) was stirred at 0-5°C and aqueous solution of sulphamic acid (0.455 g, 4.5 mmol) was added. The reaction mass was stirred for 20 min. Then aqueous solution of sodium chlorite (0.421 g, 4.5 mmol) was added and the reaction was further continued at RT for 18 h. After completion of reaction, reaction mixture was concentrated under reduced pressure and reaction mass was quenched with water. Solid obtained was filtered off and vacuum dried to afford 0.332 g of desired product. 1H NMR (DMSO-de): δ 4.27 (s, 4H), 6.84 (t, J = 7.2 Hz, 1H), 7.02 (d, J = 7.8 Hz, 1H), 7.20 (d, J= 7.5 Hz, 1H), 12.5 (bs, 1H); MS [M+H]+: 181.12. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 18 h; | To a solution of 2,3-dihydrobenzo[£][l,4]dioxine-5-carboxylic acid (5.00 g, 28.0 mmol) in THF (150 mL) at 0 °C was added lithium aluminium hydride (2.13 g, 56.0 mmol) in small portions. The reaction mixture was stirred at 0 °C for 10 min and stirred for a further 18 h at r.t. Water (150 mL) was added to the reaction mixture which was extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with brine (100 mL), dried over Na2S04, filtered and concentrated under reduced pressure to obtain 20 as yellow oil (3.22 g, 99percent). 1H NMR (CDC13) δ 6.87-6.79 (m, 3H), 4.66 (s, 2H), 4.32-4.30 (m, 2H), 4.28-4.25 (m, 2H), 2.19 (bs, 1H). Found: [M+H-18]=149.5 |
99% | With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 18 h; | 4.1.1.1. 6-Bromo-3-((2,3-dihydrobenzo[b][1,4]dioxin-5-yl)methyl)-2-methoxyquinoline (VI: Y = 2,3-O(CH2)2O–). To a solution of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylic acid (5.00 g, 28.0 mmol)in THF (150 mL) at 0 C was added lithium aluminium hydride(2.13 g, 56.0 mmol) in small portions. The reaction mixture wasstirred at 0 C for 10 min and stirred for a further 18 h at 20 C.Water (150 mL) was added to the reaction mixture which wasextracted with EtOAc (2 100 mL). The combined organic layerswere washed with brine (100 mL), dried over Na2SO4, filteredand concentrated under reduced pressure to obtain (2,3-dihydrobenzo[b][1,4]dioxin-5-yl)methanol as a yellow oil (3.22 g,99percent). 1H NMR (CDCl3, 400 MHz) d 6.87–6.79 (m, 3H), 4.66 (s, 2H),4.32–4.30 (m, 2H), 4.28–4.25 (m, 2H), 2.19 (bs, 1H). Found: [M+H-18] = 149.5. |
[ 5722-93-0 ]
2-Hydroxy-4,5-dimethoxybenzoic acid
Similarity: 0.94
[ 4442-54-0 ]
2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid
Similarity: 0.92
[ 25045-36-7 ]
2-Methoxy-5-methylbenzoic acid
Similarity: 0.92
[ 704-45-0 ]
4-Methyl-2-methoxybenzoic acid
Similarity: 0.92
[ 261767-10-6 ]
Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate
Similarity: 0.94
[ 4442-54-0 ]
2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid
Similarity: 0.92
[ 29668-44-8 ]
2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde
Similarity: 0.80
[ 823225-66-7 ]
Methyl 8-bromo-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate
Similarity: 0.79
[ 2879-20-1 ]
1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone
Similarity: 0.74